Shares of Jaguar Health, Inc. (NASDAQ:JAGX – Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.13 and traded as high as $0.30. Jaguar Health shares last traded at $0.30, with a volume of 43,507,240 shares.
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on Jaguar Health in a research note on Wednesday. They set a “sell” rating on the stock.
Get Our Latest Research Report on Jaguar Health
Jaguar Health Price Performance
Jaguar Health Company Profile
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Read More
- Five stocks we like better than Jaguar Health
- What is Put Option Volume?
- Garmin Navigates to New Highs Driven By Wearables Trend
- 3 Stocks to Consider Buying in October
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
